Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Arbor Photonics was a developer of high-power fiber lasers and specialty optical fibers based on its proprietary Chirally-Coupled Core (3C) technology. Founded in 2007 as a spin-out from the University of Michigan, the company provided laser solutions for industrial materials processing, microelectronics manufacturing, and medical device fabrication. Its 3C technology enabled high-brightness, single-mode output from large-core fibers, overcoming traditional power-scaling limitations in fiber lasers. The company was backed by investors including Arboretum Ventures and RPM Ventures. In November 2012, Arbor Photonics was acquired by nLIGHT, a global leader in high-power semiconductor and fiber lasers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Arbor Photonics.